Significance and impact of bisphosphonate-induced acute phase responses.
about
Expert consensus on the diagnosis and treatment of bone metastasis in lung cancer (2014 version)Comparison of the efficacy and safety of denosumab versus bisphosphonates in breast cancer and bone metastases treatment: A meta-analysis of randomized controlled trials.Acute effects of intravenous administration of pamidronate in patients with osteoporosis.Zoledronic acid: clinical utility and patient considerations in osteoporosis and low bone massNCCN Task Force Report: Bone Health in Cancer Care.Local application of ibandronate/gelatin sponge improves osteotomy healing in rabbits.The role of bisphosphonates in multiple myeloma: mechanisms, side effects, and the future.Influence of Zoledronic Acid on Atrial Electrophysiological Parameters and Electrocardiographic Measurements.Bone-Targeted Agents for the Management of Breast Cancer Patients with Bone MetastasesBone-targeted agents and skeletal-related events in breast cancer patients with bone metastases: the state of the artToxicities following treatment with bisphosphonates and receptor activator of nuclear factor-κB ligand inhibitors in patients with advanced prostate cancer.A pilot trial of intravenous pamidronate for chronic low back pain.Management of castration-resistant prostate cancer: bisphosphonates and emerging therapies.Managing bone health with zoledronic acid: a review of randomized clinical study results.Bisphosphonate-Induced Orbital Inflammation: A Case Series and Review.Zoledronic acid induces apoptosis and autophagy in cervical cancer cells.Denosumab versus zoledronic acid for treatment of bone metastases in men with castration-resistant prostate cancer: a randomised, double-blind study.Comparison between zoledronic acid and clodronate in the treatment of prostate cancer patients with bone metastases.Acute retinal pigment epithelial detachment secondary to pamidronate administration.
P2860
Q27028138-28A58087-F42C-4A5C-BEBD-36BA7FFDC312Q33727640-CD6185E0-20AB-4C01-8630-AFC1ABAC9DE0Q34073677-52170544-783C-4BC5-98A1-8BAA86B015DBQ34389524-73F6B025-C02B-4B27-A45A-CDD2C424C105Q34617936-B0FF6613-68A7-49BA-B2F6-609189A06931Q35581742-E06E4F9E-BF18-4E91-8002-11D50BCE190BQ35584866-A9E133E9-264A-4CC3-969B-6C27220C5893Q35732066-346FB79F-2054-49BF-8F52-2DF7E3FAD3D7Q35750641-7F05AD6F-6F17-4E10-9B60-6A73EF6C5B28Q36278556-DBE5F04A-82E6-4E69-9F0B-9EBDE8D84B6CQ36553506-B1EA87E0-E49F-4460-864F-7A150F6009F4Q37626310-F677D402-E586-45E6-900C-C7D4653A8771Q37812612-11A632BD-5219-4133-9B1F-51127ADF98D4Q37823605-881655C5-D2AC-4BB1-A8ED-29FCE34A8E1DQ38625982-E5137948-FEA6-424D-863E-6BF399971767Q38964271-86262C02-A478-49D7-9996-6459C1D81590Q41904942-0CBDA9CA-37BE-438C-9C40-2B7D0A6384F8Q44951925-0D8FCB7C-AF08-4335-899A-68F00C98A693Q46346131-99AD897F-C7AF-4E2D-A330-03552A2E429A
P2860
Significance and impact of bisphosphonate-induced acute phase responses.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on December 2007
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Significance and impact of bisphosphonate-induced acute phase responses.
@en
Significance and impact of bisphosphonate-induced acute phase responses.
@nl
type
label
Significance and impact of bisphosphonate-induced acute phase responses.
@en
Significance and impact of bisphosphonate-induced acute phase responses.
@nl
prefLabel
Significance and impact of bisphosphonate-induced acute phase responses.
@en
Significance and impact of bisphosphonate-induced acute phase responses.
@nl
P2860
P356
P1476
Significance and impact of bisphosphonate-induced acute phase responses.
@en
P2093
Catherine Van Poznak
Karin Olson
P2860
P304
P356
10.1177/1078155207080806
P577
2007-12-01T00:00:00Z